Kevetrin

kevetrin · Cellceutix Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Kevetrin, covering 2016-02-24 to 2018-12-27. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of Kevetrin in Subjects With Ovarian Cancer [Phase 2]